Skip to main content

and
  1. Article

    Open Access

    Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma

    Wanting Qiang, Lina **, Tiancheng Luo, Yanchun Jia, **g Lu in Blood Cancer Journal (2023)

  2. Article

    Open Access

    High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer

    Though BRCA1 mutation is the most susceptible factor of breast cancer, its prognostic value is disputable. Here in this study, we use a novel method which based on whole-genome analysis to evaluate the chromosome...

    Liang Zhu, Jia-Ni Pan, Ziliang Qian, Wei-Wu Ye, **ao-Jia Wang in Breast Cancer (2022)

  3. No Access

    Article

    Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse

    Chromosomal instabilities (CIN) of plasma cell-free DNA (cfDNA) are common in breast cancer. We aimed to investigate the value of cfDNA CIN in monitoring the breast cancer relapse and additionally to compare i...

    Huanhuan Zhou, **ao-Jia Wang, **yi Jiang in Breast Cancer Research and Treatment (2019)

  4. Article

    Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer

    Gastric cancer (GC) is an aggressive malignancy whose mechanisms of development and progression are poorly understood. The identification of prognosis-related genomic loci and genes may suffer from the relativ...

    **aohong Wang, Yiqiang Liu, Duanfang Shao, Ziliang Qian, Zhengwei Dong in Gastric Cancer (2016)

  5. Article

    Open Access

    Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma

    MAPK7/ERK5 (extracellular-signal-regulated kinase 5) functions within a canonical three-tiered MAPK (mitogen activated protein kinase) signaling cascade comprising MEK (MAPK/ERK kinase) 5, MEKK(MEK kinase) 2/3...

    Paul R. Gavine, Mei Wang, Dehua Yu, Eva Hu, Chunlei Huang, Jenny **a in BMC Cancer (2015)